IPP Bureau
DxVx plans to make a license-in agreement of OVM-200
By IPP Bureau - November 25, 2023
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Lupin receives tentative approval from USFDA for Canagliflozin Tablets
By IPP Bureau - November 24, 2023
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor
Lupin receives approval from USFDA for Bromfenac Ophthalmic Solution
By IPP Bureau - November 24, 2023
Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain
AstraZeneca Pharma India receives permission to Import formulations of new drug for sale
By IPP Bureau - November 23, 2023
The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
Merck to acquire Caraway Therapeutics
By IPP Bureau - November 23, 2023
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Fosun Pharma USA and Treehill Partners to invest in biopharma space
By IPP Bureau - November 23, 2023
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Lupin launches Vilfuro-G for COPD Management in India
By IPP Bureau - November 23, 2023
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Prevest Denpro launches range of innovative oral hygiene products ‘Oradox’
By IPP Bureau - November 23, 2023
The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care
Strides receives USFDA approval for generic Suprep bowel prep kit
By IPP Bureau - November 23, 2023
The Product will be manufactured at the company's facility in Bengaluru
Evive Biotech and Acrotech Biopharma receive FDA approval of Ryzneuta
By IPP Bureau - November 23, 2023
Lupin receives tentative approval from USFDA for Dapagliflozin Tablets
By IPP Bureau - November 22, 2023
Dapagliflozin Tablets (RLD Farxiga) had estimated annual sales of USD 7282 million in the US
Lupin receives approval from USFDA for Pitavastatin Tablets
By IPP Bureau - November 22, 2023
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
Truqap plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
By IPP Bureau - November 22, 2023
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
Azelis inks distribution agreement with Beneo in India and Bangladesh
By IPP Bureau - November 22, 2023
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
LTTS, NVIDIA to unveil Gen AI and software defined architecture for medical devices
By IPP Bureau - November 21, 2023
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components
